More specifically, FOXM1 is overexpressed in basal-type BC and leads to malignant phenotypes through the upregulation of AURKB, CCNB1, and MYC and indirect upregulation of ZEB1 and ZEB2 via miR-200b downregulation (Katoh et al., 2013). This evidence concerns the gene ZEB2 and breast cancer.